Celemin Nephro

Celemin Nephro Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name Celemin Nephro
Generic Human Milk Based Amino Acid
Type Bottle
Therapeutic Class Parenteral Nutritional preparations
Manufacturer Claris Lifesciences Limited, Otsuka Opv Co, Ltd,
Available Country India, Philippines
Last Updated: September 19, 2023 at 7:00 am
Celemin Nephro
Celemin Nephro

Uses

Burn injury, Cancer, Hepatic insufficiency, Malnutrition, Parenteral nutrition, Protein deficiency or Sarcopenia, Renal insufficiency, Surgery, Trauma

Dosage

Celemin Nephro dosage

Infants and Children: The recommended rate of infusion is 28-35 ml/kg body weight per day. It should be infused slowly, at rates 1.4- 2.8 ml (30-60 drops) per minute.

Side Effects

It is usually well tolerated. Yet nausea, vomiting, flushing and sweating have been observed during infusion of amino acid IV at rates exceeding the recommended maximal rate. Hypersensitivity reactions have been reported. Like all hypertonic infusion solution, thrombophlebitis may occur when peripheral veins are used. The incidence may be reduced by the simultaneous infusion of 10% fat emulsion. If it is infused to severely ill patients, premature infants, hyperphenylalaninemia may occur.

Precaution

Hyperphenylalaninemia has been noted in severely ill, premature infants. In these patients, monitoring of the phenylalanine levels is recommended and the infusion rate adjusted as needed. Do not use if the solution is turbid or contains particles. Discard any unused portion.

Pregnancy & Breastfeeding use

Pregnancy Category- Not Classified. FDA has not yet classified the drug into a specified pregnancy category.

Contraindication

Contraindicated in patients with inborn errors of amino acids metabolism. Moreover, amino acid should not be used in patients with hepatic coma or metabolic disorders involving impaired nitrogen utilization.

Innovators Monograph

You find simplified version here Celemin Nephro


*** Taking medicines without doctor's advice can cause long-term problems.
Share